HighPoint Advisor Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.43M | Sell |
20,213
-65,564
| -76% | -$7.57M | 0.1% | 178 |
|
|
2025
Q4 | $9.03M | Buy |
85,777
+18,902
| +28% | +$1.77M | 0.2% | 100 |
|
|
2025
Q3 | $5.61M | Sell |
66,875
-6,459
| -9% | -$532K | 0.27% | 62 |
|
|
2025
Q2 | $5.81M | Buy |
73,334
+8,230
| +13% | +$654K | 0.31% | 54 |
|
|
2025
Q1 | $5.51M | Buy |
65,104
+2,661
| +4% | +$248K | 0.32% | 53 |
|
|
2024
Q4 | $5.49M | Sell |
62,443
-8,601
| -12% | -$887K | 0.3% | 51 |
|
|
2024
Q3 | $8.07M | Sell |
71,044
-7,861
| -10% | -$934K | 0.47% | 37 |
|
|
2024
Q2 | $9.09M | Buy |
78,905
+15,601
| +25% | +$2.01M | 0.54% | 32 |
|
|
2024
Q1 | $8.19M | Buy |
63,304
+656
| +1% | +$80.9K | 0.58% | 31 |
|
|
2023
Q4 | $7.85M | Buy |
+62,648
| New | +$6.5M | 0.56% | 32 |
|
|
2022
Q2 | $5.96M | Buy |
+64,027
| New | +$5.68M | 0.65% | 29 |
|
|
2021
Q3 | $3.61M | Sell |
48,044
-6,250
| -12% | -$475K | 0.35% | 57 |
|
|
2021
Q2 | $4.22M | Buy |
54,294
+5,578
| +11% | +$415K | 0.43% | 51 |
|
|
2021
Q1 | $3.55M | Buy |
48,716
+1,845
| +4% | +$136K | 0.41% | 52 |
|
|
2020
Q4 | $3.36M | Buy |
46,871
+4,266
| +10% | +$326K | 0.41% | 55 |
|
|
2020
Q3 | $3.27M | Sell |
42,605
-380
| -0.9% | -$29.8K | 0.59% | 33 |
|
|
2020
Q2 | $3.2M | Buy |
42,985
+614
| +1% | +$46.2K | 0.68% | 30 |
|
|
2020
Q1 | $3.29M | Buy |
42,371
+2,625
| +7% | +$206K | 0.78% | 28 |
|
|
2019
Q4 | $3.41M | Buy |
39,746
+7,956
| +25% | +$653K | 0.7% | 32 |
|
|
2019
Q3 | $2.54M | Buy |
31,790
+272
| +0.9% | +$21.8K | 0.56% | 39 |
|
|
2019
Q2 | $2.44M | Sell |
31,518
-1,427
| -4% | -$109K | 0.57% | 43 |
|
|
2019
Q1 | $2.45M | Sell |
32,945
-747
| -2% | -$55.9K | 0.6% | 41 |
|
|
2018
Q4 | $2.55M | Buy |
33,692
+851
| +3% | +$60.1K | 0.67% | 38 |
|
|
2018
Q3 | $2.27M | Sell |
32,841
-649
| -2% | -$41.3K | 0.62% | 38 |
|
|
2018
Q2 | $2.2M | Sell |
33,490
-244
| -0.7% | -$13.8K | 0.59% | 40 |
|
|
2018
Q1 | $2.01M | Buy |
33,734
+8,281
| +33% | +$447K | 0.55% | 41 |
|
|
2017
Q4 | $1.33M | Buy |
25,453
+3,748
| +17% | +$208K | 0.38% | 61 |
|
|
2017
Q3 | $1.15M | Buy |
21,705
+580
| +3% | +$35.2K | 0.36% | 67 |
|
|
2017
Q2 | $1.27M | Hold |
21,125
| – | – | 0.41% | 57 |
|
|
2017
Q1 | $1.27M | Buy |
21,125
+1,630
| +8% | +$98.9K | 0.41% | 57 |
|
|
2016
Q4 | $1.23M | Sell |
19,495
-11,723
| -38% | -$686K | 0.4% | 60 |
|
|
2016
Q3 | $1.87M | Buy |
31,218
+1,363
| +5% | +$79.7K | 0.66% | 31 |
|
|
2016
Q2 | $1.78M | Buy |
29,855
+13,334
| +81% | +$710K | 0.62% | 35 |
|
|
2016
Q1 | $894K | Sell |
16,521
-1,317
| -7% | -$64.5K | 0.55% | 48 |
|
|
2015
Q4 | $874K | Buy |
17,838
+9,245
| +108% | +$466K | 0.57% | 48 |
|
|
2015
Q3 | $405K | Buy |
+8,593
| New | +$456K | 0.45% | 89 |
|
Other funds holding MRK
VCM
VPM
HighPoint Advisor Group's MRK Position: Q1 2026 in Review
HighPoint Advisor Group reduced its Merck (MRK) stake by 76% in Q1 2026, selling an estimated $7.57M and leaving 20,213 shares worth $2.43M. The position accounts for 0.1% of the portfolio, ranked #178.
HighPoint Advisor Group first reported a position in MRK in Q3 2015 and has held it in 36 quarters since. The position peaked at $9.09M in Q2 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- HighPoint Advisor Group held 20,213 shares of Merck worth $2.43M as of Q1 2026.
- HighPoint Advisor Group sold 65,564 Merck shares in Q1 2026, an estimated $7.57M.
- Merck made up 0.1% of HighPoint Advisor Group's portfolio in Q1 2026, its #178 holding.
- HighPoint Advisor Group first reported a position in Merck in Q3 2015 and has held it in 36 quarters since.
- HighPoint Advisor Group's Merck position peaked at $9.09M in Q2 2024.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on HighPoint Advisor Group's 13F filing for Q1 2026, filed 14 May 2026.